We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.00 | 0.18% | 1,673.00 | 1,674.00 | 1,675.00 | 1,679.50 | 1,658.50 | 1,661.50 | 7,034,492 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.99 | 68.96B |
TIDMGSK
RNS Number : 3612M
GlaxoSmithKline PLC
20 January 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Ms E Walmsley ==== ====================================== ==================================================== b) Position/status Chief Executive Officer ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP13.9340 920 =========================================== ========================== ====================== GBP13.9340 924 ========================== ====================== GBP13.9340 740 ========================== ====================== d) Aggregated information 2,584 ==== Aggregated volume GBP13.9340 Price =========================================== ==================================================== e) Date of the transaction 2021-01-18 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Dr H Barron ==== ======================================= =================================================== b) Position/status Chief Scientific Officer and President, R&D ==== ======================================= =================================================== c) Initial notification/ Initial notification amendment ==== ======================================= =================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ======================================= =================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= =================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= =================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 14 January 2021 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================= =================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================= ========================= ====================== $ 38.1600 539 ============================================ ========================= ====================== $ 38.1600 423 ========================= ====================== d) Aggregated information 962 ==== Aggregated volume $38.1600 Price ============================================ =================================================== e) Date of the transaction 2021-01-18 ==== ======================================= =================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= =================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== =========================================================================================== a) Name Mr R Connor ==== ===================================== ==================================================== b) Position/status President, Global Vaccines ==== ===================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== =========================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== =========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== =========================== =====================
GBP 13.9340 195 ========================================== =========================== ===================== GBP 13.9340 241 =========================== ===================== GBP 13.9340 233 =========================== ===================== d) Aggregated information 669 ==== Aggregated volume GBP 13.9340 Price ========================================== ==================================================== e) Date of the transaction 2021-01-18 ==== ===================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================= a) Name Ms D Conrad ==== ===================================== ====================================================== b) Position/status SVP Human Resources ==== ===================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================= a) Name GlaxoSmithKline plc ==== ===================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ============================ ===================== GBP 13.9340 96 ======================================================================= ===================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ==================================================================== ============================ e) Date of the transaction 2021-01-18 ==== ===================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Mr J Ford ==== ====================================== ====================================================== b) Position/status Senior Vice President and General Counsel ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GlaxoSmithKline plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP13.9340 137 ======================================================================= ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ==================================================================== ============================= e) Date of the transaction 2021-01-18 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================= a) Name Mr J Ford ==== ======================================= ==================================================== b) Position/status Senior Vice President and General Counsel ==== ======================================= ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================= ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================= a) Name GlaxoSmithKline plc ==== ======================================= ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= ==================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 14 January 2021 on ADSs held in the Company's Deferred Annual Bonus
Plan ==== ======================================= ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================= ========================= ====================== $ 38.1600 46 ========================= ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ======================================== ======================================================== e) Date of the transaction 2021-01-18 ==== ======================================= ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== =========================================================================================== a) Name Mr N Hirons ==== ===================================== ==================================================== b) Position/status SVP, Global Ethics & Compliance ==== ===================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== =========================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== =========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== =========================== ===================== GBP 13.9340 102 ========================================== =========================== ===================== GBP 13.9340 72 =========================== ===================== GBP 13.9340 101 =========================== ===================== d) Aggregated information 275 ==== Aggregated volume GBP 13.9340 Price ========================================== ==================================================== e) Date of the transaction 2021-01-18 ==== ===================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================= a) Name Ms S Jackson ==== ===================================== ====================================================== b) Position/status SVP, Global Communications & CEO Office ==== ===================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================= a) Name GlaxoSmithKline plc ==== ===================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ============================ ===================== GBP 13.9340 58 ======================================================================= ===================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ==================================================================== ============================ e) Date of the transaction 2021-01-18 ==== ===================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================= a) Name Mr I Mackay ==== ===================================== ====================================================== b) Position/status Chief Financial Officer ==== ===================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================= a) Name GlaxoSmithKline plc ==== ===================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================= a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== ============================ ===================== GBP 13.9340 499 ======================================================================= ===================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ==================================================================== ============================ e) Date of the transaction 2021-01-18 ==== ===================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ====================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr B McNamara ==== ======================================= =================================================== b) Position/status CEO, GSK Consumer Healthcare ==== ======================================= =================================================== c) Initial notification/ Initial notification amendment ==== ======================================= =================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ======================================= =================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= =================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= =================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 14 January 2021 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================= =================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== --------------------------------------- ========================= ====================== $ 38.1600 90 -------------------------------------------- ========================= ====================== $ 38.1600 96 ========================= ====================== $ 38.1600 78 ------------------------- ---------------------- d) Aggregated information 264 ==== Aggregated volume $ 38.1600 Price ============================================ =================================================== e) Date of the transaction 2021-01-18 ==== ======================================= =================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= =================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr L Miels ==== ====================================== ==================================================== b) Position/status President, Global Pharmaceuticals ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP13.9340 185 =========================================== ========================== ====================== GBP13.9340 224 ========================== ====================== GBP13.9340 256 ========================== ====================== d) Aggregated information 665 ==== Aggregated volume GBP13.9340 Price =========================================== ==================================================== e) Date of the transaction 2021-01-18 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr D Redfern ==== ====================================== ==================================================== b) Position/status Chief Strategy Officer ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP13.9340 190 =========================================== ========================== ====================== GBP13.9340 228 ========================== ====================== GBP13.9340 164 ========================== ====================== d) Aggregated information 582 ==== Aggregated volume GBP13.9340 Price =========================================== ==================================================== e) Date of the transaction 2021-01-18 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr R Simard ==== ====================================== ==================================================== b) Position/status President, Pharmaceuticals Supply Chain ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP13.9340 82 =========================================== ========================== ====================== GBP13.9340 116 ========================== ====================== d) Aggregated information 198 ==== Aggregated volume GBP13.9340 Price =========================================== ==================================================== e) Date of the transaction 2021-01-18 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Ms K Terrell ==== ======================================= =================================================== b) Position/status Chief Digital & Technology Officer ==== ======================================= =================================================== c) Initial notification/ Initial notification amendment ==== ======================================= =================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ======================================= =================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= =================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= =================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 14 January 2021 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================= =================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================= ========================= ====================== $ 38.1600 32 ============================================ ========================= ====================== $ 38.1600 114 ========================= ====================== $ 38.1600 79 ========================= ====================== d) Aggregated information 225 ==== Aggregated volume $ 38.1600 Price ============================================ =================================================== e) Date of the transaction 2021-01-18 ==== ======================================= =================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= =================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr P Thomson
==== ====================================== ==================================================== b) Position/status President, Global Affairs ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 14 January 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP13.9340 128 =========================================== ========================== ====================== GBP13.9340 133 ========================== ====================== GBP13.9340 94 ========================== ====================== d) Aggregated information 355 ==== Aggregated volume GBP13.9340 Price =========================================== ==================================================== e) Date of the transaction 2021-01-18 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ====================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEBLFLFFLBBBF
(END) Dow Jones Newswires
January 20, 2021 10:02 ET (15:02 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions